PROKProKidney Corp.
$1.67-44% 1Y
$1.67
$1.3352 weeks$3.30
Price
-44%1YEnd-of-day closes, not the intraday tick.
The five questions
2 of 5 availableOnly two of the five can be answered for PROK today. The rest need figures this filer has not published. The tabs above still show whatever data does exist.
- Is the business good?not enough filed
- Is it safe?Watch
- Is the price fair?not enough filed
- Is it growing?not enough filed
- What is the market doing?Watch
P/En/a
Market value$504.4M
1 year-44%
5 years-83%
The next results filing is expected around Nov 9, 2026, the same week as a year ago.
What the company said
The company's own words from its current reports to the SEC, newest first
- Aug 10, 2026ProKidney Reports Second Quarter 2026 Financial Results and Business Highlights.Earnings release · press release
- May 15, 2026The statistical powering assumption for the surrogate endpoint (eGFR slope) analysis in the PROACT 1 study has been updated to 80%, while the statistical powering assumption for the confirmatory endpoint analysis remains at 80%.Earnings release · Form 8-K
- Mar 18, 2026ProKidney Reports Full Year 2025 Financial Results and Business Highlights.Earnings release · press release
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
Biotechnology
The closest names by size in the same industry